Patient preferences for maintenance PARP inhibitor therapy in ovarian cancer treatment.
暂无分享，去创建一个
F. Johnson | L. Havrilesky | A. Lorenzo | S. Reed | J. Ehrisman | J. González | A. Alvarez Secord | Jui-Chen Yang | Stephanie L Lim | S. Reed | F. Reed Johnson | Juan Marcos González